Skip to main content
Top

International Journal of Clinical Pharmacy

Issue 1/2005

Content (14 Articles)

Editorial

Janine M. Traulsen, Anna Birna Almarsdóttir

Heterogeneity in the evaluation of observational studies by Italian ethics committees

Benedetta Santarlasci, Andrea Messori, Filippo Pelagotti, Sabrina Trippoli, Monica Vaiani

The argument for pharmaceutical policy

Janine Morgall Traulsen, Anna Birna Almarsdóttir

Withdrawal symptom after discontinuation of transdermal fentanyl at a daily dose of 0.6 mg

Chie Ishihara, Hiroki Konishi, Mikio Chiba, Tokuzo Minouchi, Yoshihiro Endo, Akira Yamaji

Pharmacogenetics as a tool in the therapy of schizophrenia

Bob Wilffert, Rianne Zaal, Jacobus R.B.J. Brouwers

Initial benzodiazepine use and improved health-related quality of life

Rolf van Hulten, Bart Teeuw, Albert Bakker, Hubert G. Leufkens

Desire for information about drugs: a survey of the need for information in psychiatric in-patients

Lieven Zwaenepoel, Rita Bilo, Willy De Boever, Marc De Vos, Johan Reyntens, Vera Hoorens, Walter Sermeus, Gert Laekeman

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine